Public Health Genomics

Marketing Genomics: How to convert one who does not want to be converted

Recently, I have been engaged in one of the best academic experiences I have had in my many years of formal education as well as many professional conferences. It was at the University of Minnesota School of Public Health Summer Institute. One of the courses that I have been taking is Genomics. We have had many knowledgeable experts with great communicating skills as well as well informed multi-disciplined student participants.

After one of our sessions I enetered in a conversation about stem cell research with someone that strongly opposes the entire issue of stem cell research based on his religious belief that scientists are entering in the realm of things that are really God's business. I was stopped for a minute, but not entirely surprised because we have had discussions about similiar issues and his response was usually very closed end and not allowing for a dialogue.

| read more

Putting the "Public" Into Public Health Genomics

I graduated last year from Portland State University (Oregon) with a double major in History and Philosophy and a certificate in Biomedical ethics.  I am currently enrolled in a three-week course in public health genomics as a part of a Public Health Summer Institute at the University of Minnesota.  Even with that academic background, a limited medical background from the patient side, and a limited (yet) informed exposure to genetics in a senior capstone class I took last year at PSU, "Democracy, Ethics, and Civic Discourse in the Gene Age," I was completely overwhelmed by the scientific content and language of a recent presentation on Pharmacogenomics (the general study of all of the many different genes that determine drug behavior, that is, an attempt to understand not only the molecular composition of genetic variants (SNPs) but also the behavior of those variants, including how those genes affect drug receptor sites.

| read more | TylerJ's blog

Public Health Genomics

Geneforum is creating a new thread on public health genomics, a way to think about public health problems in the Genetic Age. In the opinion of many, Genomics, the study of the complete set of genetic information in an organism, will be to the 21st century what infectious disease was to 20th century public health. According to Muin Khoury, Director, Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, "The ultimate challenge of public health genomics is to determine the benefits of using genetic informaiton to target interventions that improve health and prevent disease."

| read more | gfowler's blog

The Public Perceptions of the Rewards and Risks of Genetic Research: The Oregon Story

by Gregory Fowler and Barry Anderson
Greg Fowler is an Associate Clinical Professor of Public Health, Oregon Health Sciences University, Portland, Oregon and Executive Director of Geneforum.org (www.geneforum.org). Barry Anderson is Emeritus Professor of Psychology, Department of Psychology, Portland State University, Portland, Oregon.
The genomics revolution rolls on, promising tremendous improvements in our ability to secure a new level of physical well-being, yet, at the same time, creating a sense of unease about some of its possible consequences. With the growing power to obtain accurate genetic information about individuals the question we need to ask ourselves is: Who should have access to this information? And under what conditions?
| read more